Organ Preservation Solution Market Key Players and Opportunities by 2031

The organ preservation solution market size is projected to reach US$ 512.62 million by 2031 from US$ 274.41 million in 2023. The market is expected to register a CAGR of 8.2% during 2023–2031. The shift toward machine perfusion technique is likely to remain a key trend in the market.

Organ Preservation Solution Market Analysis

Organ preservation solution is a specialized fluid used to preserve organs such as kidney, heart, liver, and pancreas outside the body during transplantation. Organ transplantation is the only treatment option for patients with end-stage organ failure. The increasing prevalence of chronic diseases and the rising need for organ transplantation are the factors favoring the organ preservation solution market progress.

Organ Preservation Solution Market Overview

In 2023, the Canadian Institute for Health Information (CIHI) reported that 3,428 organ transplant procedures were performed in the country. Of these transplants, 83% used organs from deceased donors, and 17% used organs from living donors. Thus, the growing number of organ transplant procedures serves growth prospects for the organ preservation solution market. Governments of various countries are collaborating with the market players to understand perfusion systems for better health. For instance, China has installed XVIVO perfusion in its hospitals, and the company is also seeking approval from CFDA.

Organ Preservation Solution Market: Strategic Insights

Organ Preservation Solution Market Drivers and Opportunities

Increasing Prevalence of Chronic Diseases Favors Market

Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately 1 in every 10 people worldwide. A study published by the National Kidney Foundation in 2020 predicted that ~35.0% of the diabetic population over the age of 20 would develop chronic kidney disease over time. As per the Health Resources and Services Administration (HRSA), ~88,901 patients were on the kidney waiting list as of 2022. Each day, nearly 21 individuals die while waiting for organ transplantation, whereas over 120,000 men, women, and children seek life-saving organ transplantation procedures. Chronic diseases, which may be congenital or acquired, can lead to gradual damage to organs over time. Chronic diseases typically don't resolve on their own, but there may be ways to slow down or mitigate the damage caused by the condition. It may take decades for this damage to build up to the point where it noticeably affects patients' organ function or requires medical intervention. Chronic heart diseases, including coronary artery disease and congenital heart disease, can lead to progressive heart failure. Thus, the mounting prevalence of chronic diseases increases the demand for organ preservation solutions during organ transplantation procedures.

Surging Strategic Initiatives by Market Players to Create Market Opportunities

Various market players focus on product launches or strategic collaborations to develop advanced products that help ease the treatment of chronic disorders. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years.

• In November 2023, Paragonix Technologies launched a comprehensive donor organ procurement, preservation, and transportation services network. This expansion includes the establishment of seven strategically located procurement hubs across the US, designed to optimize coordination and logistics for the transplant community. These support hubs, available 24/7, consist of a team of over 50 distinguished procurement professionals, including certified surgeons and preservationists, all devoted to advancing organ transplantation.

• In April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart System for using it with organs procured from donors after circulatory death. The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donors-after-circulatory-death (DCD) hearts.

Thus, a surge in product approvals, launches, and strategic collaborations is likely to create considerable growth opportunities for the organ preservation solution market in the future.

Organ Preservation Solution Market Report Segmentation Analysis

Key segments that contributed to the derivation of the organ preservation solution market analysis are product, type, application, and end user.

• Based on Product, the organ preservation solution market is segmented into University of Wisconsin Solution, Custodiol HTK, Perfadex, Hypothermosol, and Others. The University of Wisconsin Solution segment held the largest market share in 2023.
• By organ type, the market is segmented into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest share of the market in 2023.
• By application, the market is segmented into Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others. The static cold storage segment held the largest share of the market in 2023.
• Based on end user, the market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment dominated the market in 2023.

Organ Preservation Solution Market Share Analysis by Geography

The geographic scope of the organ preservation solution market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. The North America organ preservation solution market has been analyzed on the basis of the US, Canada, and Mexico. Increasing adoption of technologically advanced products and solutions, and surging number of organ transplants are the factors benefiting the organ preservation solution market in this region. The US held the largest share of the organ preservation solution market in North America in 2023. In June 2024, the American Kidney Fund, Inc. reported that up to 37 million Americans have kidney disease, and ~808,000 Americans are affected by kidney failure. More than 557,000 Americans are undergoing dialysis treatment. The prevalence of kidney disease is rising and currently affects over 1 in 7 (or 14%) of American adults.

The rising number of approvals from the US Food and Drug Administration (FDA), and the presence of market players further boost the organ preservation solution market growth in the US. In April 2022, TransMedics Group, Inc. announced that it received premarket FDA approval for its OCS Heart System, which can be used with organs from donors after circulatory death (DCD). The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death (DCD) hearts.

Organ Preservation Solution Market Regional Insights

The regional trends and factors influencing the Organ Preservation Solution Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Organ Preservation Solution Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Organ Preservation Solution Market Report Scope

Organ Preservation Solution Market Players Density: Understanding Its Impact on Business Dynamics

The Organ Preservation Solution Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Organ Preservation Solution Market News and Recent Developments

The organ preservation solution market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the organ preservation solution market are listed below:

• Bridge to Life has reintroduced EasiSlush to the US market, meeting high demand for easy-to-use sterile slush for organ transplantation. EasiSlush is renowned for its ease of use, high quality, and portability, making it the preferred choice for organ transplant professionals.  (Source: Bridge to Life, Company Website, February 2024)
• OrganOx partnered with Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases. As part of the partnership, OrganOx supplied metra devices to Ochre Bio and its partners for evaluating novel RNA therapeutics using discarded donor livers. (Source: OrganOx, Company Website, March 2024)

Organ Preservation Solution Market Report Coverage and Deliverables

The "Organ Preservation Solution Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Organ preservation solution market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Organ preservation solution market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Organ preservation solution market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the organ preservation solution market
• Detailed company profiles